These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 11892095)
1. The potential of peptide immunotherapy in allergy and asthma. Ali FR; Kay AB; Larché M Curr Allergy Asthma Rep; 2002 Mar; 2(2):151-8. PubMed ID: 11892095 [TBL] [Abstract][Full Text] [Related]
2. The efficiency of peptide immunotherapy for respiratory allergy. Incorvaia C; Montagni M; Ridolo E Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667 [TBL] [Abstract][Full Text] [Related]
4. Unique and cross-reactive T cell epitope peptides of the major Bahia grass pollen allergen, Pas n 1. Etto T; de Boer C; Prickett S; Gardner LM; Voskamp A; Davies JM; O'Hehir RE; Rolland JM Int Arch Allergy Immunol; 2012; 159(4):355-66. PubMed ID: 22832594 [TBL] [Abstract][Full Text] [Related]
5. [Allergen-derived peptide: A promising approach in asthma]. Klein M; Magnan A; Bouchaud G Rev Mal Respir; 2019 Apr; 36(4):442-446. PubMed ID: 31006580 [TBL] [Abstract][Full Text] [Related]
6. Peptide-mediated immune responses in specific immunotherapy. Haselden BM; Kay AB; Larché M Int Arch Allergy Immunol; 2000 Aug; 122(4):229-37. PubMed ID: 10971112 [TBL] [Abstract][Full Text] [Related]
7. The relationship between allergen immunotherapy and omalizumab for treating asthma. Braido F; Corsico A; Rogkakou A; Ronzoni V; Baiardini I; Canonica GW Expert Rev Respir Med; 2015 Apr; 9(2):129-34. PubMed ID: 25578528 [TBL] [Abstract][Full Text] [Related]
8. SPIREs: a new horizon for allergic disease treatment? Worm M Expert Rev Clin Immunol; 2015; 11(11):1173-5. PubMed ID: 26166009 [TBL] [Abstract][Full Text] [Related]
9. Allergen immunotherapy with cat allergen peptides. Kay AB; Larché M Springer Semin Immunopathol; 2004 Feb; 25(3-4):391-9. PubMed ID: 15007637 [TBL] [Abstract][Full Text] [Related]
10. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study. Smith TR; Alexander C; Kay AB; Larché M; Robinson DS Allergy; 2004 Oct; 59(10):1097-101. PubMed ID: 15355469 [TBL] [Abstract][Full Text] [Related]
11. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Focke M; Swoboda I; Marth K; Valenta R Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with peptides. Moldaver D; Larché M Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007 [TBL] [Abstract][Full Text] [Related]
13. T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy. Wai CY; Leung NY; Leung PS; Chu KH Clin Exp Allergy; 2016 Mar; 46(3):491-503. PubMed ID: 26610061 [TBL] [Abstract][Full Text] [Related]
14. Peptide immunotherapy for allergic diseases. Larché M Allergy; 2007 Mar; 62(3):325-31. PubMed ID: 17298351 [TBL] [Abstract][Full Text] [Related]
16. Regulation of specific immune responses by chemical and structural modifications of allergens. Akdis CA; Blaser K Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716 [TBL] [Abstract][Full Text] [Related]
17. Epitope peptides and immunotherapy. Tanabe S Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564 [TBL] [Abstract][Full Text] [Related]